Cooperation

Orifarm is a progressive European player in the healthcare business. Our overall vision is to be no. 1 in making healthcare a better deal and in all our markets our aim is clear: to be the leading supplier - if we aren't already.

To be able to achieve this vision, we rely on strong relations both with our business partners and in national and European associations, where we aim to make our influence count.

The right Business Partner

We seek business partners with high quality products and market knowledge. In return we offer a unique market access and extensive knowledge of the markets on which we operate. Our focus is on our relations and finding the right business partners is very important to us.

We strive to be our customers' preferred supplier - and our suppliers' preferred customer. We want to create value not just for ourselves, but also for those we do business with.

Business partner - Parallel Import

Orifarm is a successful parallel importer with good prospects for the future. We have one of the largest product portfolios of parallel imported pharmaceuticals in Europe and a strong position on our many markets.

We are looking for strong and lasting business relationships with our suppliers and we can guarantee that we are a reliable and trustworthy business partner: 

• We provide you with guaranteed payments on time and access to essential market knowledge
• We offer an attractive and diversified range of products, that meet market demands
• We always do our best to create value for you as our supplier.

For further information please contact our Senior Vice President, Corporate Procurement & Research, Thomas Brandhof.

Business partner - Generics

Orifarm Generics is a fast growing supplier of generic pharmaceuticals to the Nordic countries. We have successfully established a strong position on the Nordic markets, which we continuously develop.

Orifarm Generics has successfully launched a wide varity of products both within prescription and OTC medical products. Our ambition is to always have an attractive, high quality and diversified product portfolio in order meet market demands.

We are not focused on any niches, but rather a large variety of product groups and in many different batch sizes and categories.
We provide qualified access to the Nordic market and in return we look for partners with high quality products/service, with whom we can build mutually benefiting and lasting relations. We are easy to deal with and our decision making procedures are smooth. 

To effectively meet the demands of the Nordic market, we look for suppliers who offer:
• Low cost production
• Fast/flexible decision-making and proactive communication
• Timely delivery
• Short lead times

If you are interested in working with Orifarm Generics, please contact our CEO, Orifarm Generics, Ulrik Ernst Rasmussen.

Associations

It is important for Orifarm to stay involved in the political arena and to promote the societal savings related to our two business areas, parallel import and genericsWe are therefore very much involved in both national and European associations.

Within parallel import, we are a member of the EAEPC - European Association of Euro-Pharmaceutical Companies - and the entire team in the association is working hard to remove any competition distortions (i.e. quotas, dual pricing) and correct the myths that challenge both importers and exporters (i.e. parallel imports threaten R&D).
Please visit the EAEPC website for more information.
In addition, Orifarm is member of the national parallel import associations in most of the sales markets where we are present.  

Within generics, we are a member of the EGA - European Generic and Biosimilar Medicines Association. The EGA and its members work with European national governments and the EU institutions to develop affordable solutions for pharmaceutical care and to increase Europe’s competitive strength in the global pharmaceutical medicines market. 
Please visit the EGA website for more information.
In Denmark, Norway and Sweden, we do our political lobbying through the national associations IGL, NIGEL and FGL.  

Orifarm has acquired Growth House.

Read more